Search Results

The accessa Cholesterol Panel is intended for in vitro, quantitative determination of Total Cholesterol, HDL-Cholesterol, Triglycerides and calculated LDL-Cholesterol in dried micro-serum samples ("Cholesterol Panel"). Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess cholesterol in the blood and lipid and lipoprotein metabolism disorders. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis and various liver and renal diseases. The Cholesterol Panel is not intended for use on neonates. LDL-Cholesterol cannot be determined where the triglycerides value is greater than 400 mg/dL.

The accessa Cholesterol Panel incorporates the use of two separately regulated products.

• The Home Access Micro Serum Specimen (MSS) Collection Kit (a Class I Medical Device listed with the FDA effective February 19, 2003, and manufactured under the Quality System Regulations) and
• The Home Access Health Corporation (HAHC) Clinical Chemistry . Laboratory Lipid Profile Test Methods (Regulated under CLIA number 14D0981820).

The Home Access Micro Serum Specimen Collection Kit ("MSS collection kit"), (Class I Medical Device CFR 21 Part 864.3250, registered February 19, 2003) is intended to facilitate in vitro diagnostic laboratory testing of fingerstick blood samples for a variety of clinical chemistry assays. This MSS collection kit includes a collection cassette, storage pouch and prepaid mailer along with all the materials necessary to self-collect a capillary blood sample into the blood collection/transportation cassette. The cassette is packaged along with patient/customer information and transported to the certified clinical laboratory for lipid profile testing. In its final configuration, the accessa Cholesterol Panel kit is comprised of:

• . Blood collection/transportation cassette
• Sample Return Pouch with Desiccant .
• 2 Safety lancets ●
• Gauze pad .
• Adhesive bandage .
• . Instructions for use
• Brochure: "What you need to know to keep your heart healthy" .
• Prepaid US Mail return mailer .
• Informed Consent Form .
• Outer Box .

The patient/customer follows the directions to self-collect a capillary blood sample (approximately 100 micro liters), package and mail the sample to a certified clinical laboratory for analysis using FDA-cleared reagent and analysis systems. Once the dried sample is received in the laboratory, it is accessioned, labeled and eluted into a usable serum sample. Once eluted, the sample can be assaved as a diluted serum sample using US FDA-cleared reagents. All testing is done via the Roche Cobas Mira Plus chemical analyzer and utilizes the software approved for use in the testing instrument (K920402). The clinical laboratory is located at Home Access Health Corporation.

Here's an analysis of the provided text regarding the acceptance criteria and study for the accessa Cholesterol Panel, presented in the requested format:

1. Table of Acceptance Criteria and Reported Device Performance

The provided 510(k) summary (K063852) does not explicitly state specific numeric acceptance criteria for the accessa Cholesterol Panel. Instead, it makes a general claim of "substantial equivalence" to predicate devices and venous (serum) results.

However, the key performance claim is related to comparability with venous samples. Therefore, the reported performance is the qualitative statement of "substantial equivalence."

• Total Cholesterol
• HDL-Cholesterol
• Triglycerides
• Calculated LDL-Cholesterol | Not explicitly stated (implied clinical equivalence to predicate and venous results) | "Results of clinical trials show that self-collected capillary samples onto the accessa Blood Collection Cassette provide results that are substantially equivalent to venous (serum) results for Total Cholesterol, HDL-Cholesterol and Triglycerides when analyzed using Home Access Health Laboratories modified analytical methods."

"The results of clinical trials demonstrated that self-collected capillary samples, tested using the HAHC proprietary testing algorithm, are substantially equivalent to venous (serum) results for Total Cholesterol, HDL-Cholesterol, Triglycerides and calculated LDL-Cholesterol." |

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size: The document does not specify a precise sample size for the clinical study. It mentions subjects, but not the number of them.
• Data Provenance: The formal clinical study was conducted independently by the LMARC Research Center in Louisville, KY, USA. The data is prospective, as samples were collected specifically for the study ("between March 2006 and May 2006").

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

There is no mention of experts being used to establish ground truth in the traditional sense of a consensus or adjudication panel. The "ground truth" for the performance comparison was established by comparing the results from the self-collected capillary samples against venipuncture samples (serum) from the same subjects. These venipuncture samples were then analyzed using FDA-cleared reagent and analysis systems at the certified clinical laboratory.

4. Adjudication Method for the Test Set

Not applicable. There was no expert adjudication method described for establishing ground truth, as ground truth was based on venipuncture serum samples analyzed by established laboratory methods.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

No, this was not a Multi-Reader Multi-Case (MRMC) comparative effectiveness study. This device is a sample collection and transport system intended for laboratory analysis, not an interpretative diagnostic tool requiring human reader comparison.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

Yes, in a sense. The core of the performance evaluation is the performance of the "accessa Cholesterol Panel" which includes the collection kit and the HAHC Clinical Chemistry Laboratory Lipid Profile Test Methods. The comparison is between the results obtained from the collected capillary samples (processed by the HAHC lab) and the venipuncture serum samples (also processed by standard lab methods). While humans are involved in laboratory analysis, the "device" itself (collection and transport) is evaluated based on the analytical results produced by the laboratory method, not on human interpretation of an image or data. The "proprietary algorithm" mentioned in the summary refers to the laboratory's internal processing and analytical methods for the eluted sample, not an AI algorithm for diagnosis.

7. The Type of Ground Truth Used

The ground truth used was venipuncture serum sample results obtained from "FDA-cleared reagent and analysis systems" using standard laboratory test methods (Total Cholesterol: Amresco Cholesterol Reagent Assay K891922, HDL Cholesterol: Wako L-Type HDL-C Reagent Assay K801834, Triglycerides: Roche Triglycerides K801298). This can be classified as a form of reference standard laboratory testing.

8. The Sample Size for the Training Set

The document does not explicitly mention a separate "training set" or its sample size. The description focuses on the "clinical study" which served as the validation for the device performance. The "proprietary algorithm" mentioned is likely the standard laboratory's analytical method, which would have been established and validated through internal lab procedures, not a distinct "training set" in the machine learning sense.

9. How the Ground Truth for the Training Set Was Established

As no specific "training set" for a machine learning algorithm is described, this question is not directly applicable. The "proprietary algorithm" refers to the HAHC Clinical Chemistry Laboratory Lipid Profile Test Methods. The ground truth for validating these laboratory methods would have been established through standard laboratory quality control, calibration, and validation procedures, typically against certified reference materials or established gold-standard methods.

Ask a specific question about this device

The Transbronchial Needle Aspiration Combination Cytology/Histology Procedural Kit is intended to retrieve and handle specimens and to prepare them for proper cytopathic and histological examination.

The Transbronchial Needle Aspiration Combination Cytology/Histology Procedural Kit contains items for obtaining and handling of cytologic and histological specimens in the context of a transbronchial aspirating needle procedure.

This submission describes a kit composed of several components, not a single device with a specific performance. The regulatory review (510(k)) found the kit substantially equivalent to legally marketed predicate devices because all its components were either already cleared, exempt from notification, or had undergone their own 510(k) process. This means the individual components were likely evaluated for their individual performance and safety, but there isn't a single study describing the overall performance of the kit in terms of specific acceptance criteria.

Therefore, many of the requested sections (e.g., sample size, expert qualifications, MRMC study, standalone performance) are not applicable to this particular 510(k) submission, as it focuses on the equivalence of a combination of components.

Here's an attempt to answer the questions based on the provided document, noting where information is not available or not applicable:

1. A table of acceptance criteria and the reported device performance

Based on the provided K983122 510(k) summary, there are no specific performance acceptance criteria or reported device performance metrics for the overall kit as a single device. The submission focuses on the substantial equivalence of its individual components to already legally marketed devices. The "performance" in this context refers to the intended function of each component, which is assumed to be met based on their prior clearances or exempt status.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

Not applicable. This 510(k) is about substantial equivalence of a medical device kit composed of pre-existing components. There is no specific test set or clinical study described in this document for the kit itself. The performance and safety of the individual components would have been established in their respective original clearances or through their general purpose exemption status.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

Not applicable. As there is no specific test set or clinical study for the kit's performance, there's no mention of experts establishing a ground truth for such a study in this submission.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

Not applicable. No test set is described for the kit's performance.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This submission is for a medical device kit for specimen collection and preparation, not an AI-assisted diagnostic tool.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

Not applicable. This submission is for a medical device kit, not a standalone algorithm.

7. The type of ground truth used (expert concensus, pathology, outcomes data, etc)

Not applicable. There is no explicit mention of a ground truth being established for the kit's performance in this document. The "ground truth" for each component implicitly relates to their established safety and efficacy for their individual intended uses, as determined during their original regulatory pathways.

8. The sample size for the training set

Not applicable. This submission does not involve a training set for an algorithm or model.

9. How the ground truth for the training set was established

Not applicable. There is no training set mentioned in this submission.

Ask a specific question about this device